Stéphane Champiat
14PUBLICATIONS
225CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Aug 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit.Camila Braganca Xavier, Clark R Andersen, JoAnn Lim
|Jun 11, 2025
Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas.Kevin J Harrington, Stephane Champiat, Joshua D Brody
|Mar 28, 2025
A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors.Oliver Bechter, Carmen Loquai, Stephane Champiat
|Aug 29, 2024
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update.Afshin Dowlati, Horst-Dieter Hummel, Stephane Champiat
|May 30, 2024
Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial.Julieta Rodriguez, Capucine Baldini, Arnaud Bayle
|May 06, 2024
Phase II Study to Determine the Antitumor Activity and Safety of Simlukafusp Alfa (FAP-IL2v) Combined with Atezolizumab in Esophageal Cancer.Hans Prenen, Sanjeev Deva, Bhumsuk Keam
Pageof 3
Frequent Collaborators
7 joint publications
Aurélien Marabelle
3 joint publications
Lambros Tselikas
3 joint publications
Antoine Italiano
3 joint publications
Samy Ammari
3 joint publications
Carlos Gomez-Roca
2 joint publications
Thibault Raoult
2 joint publications
Capucine Baldini
2 joint publications
Jean-Charles Soria
2 joint publications
Severine Mouraud
2 joint publications
Antoine Hollebecque
